Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer.
Rowan V DavidMrunal HiwaseArman A KahokehrJason LeeDavid I WatsonJohn LeungMichael E O'CallaghanPublished in: World journal of urology (2022)
This is the first study to develop a predictive model for genitourinary toxicity requiring hospitalisation amongst men with prostate cancer treated with EBRT. Patients with localised prostate cancer and concurrent BOO may benefit from TURP before EBRT.